156 related articles for article (PubMed ID: 34834478)
21. Impact of baseline Diabetic Retinopathy Severity Scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies.
Staurenghi G; Feltgen N; Arnold JJ; Katz TA; Metzig C; Lu C; Holz FG;
Br J Ophthalmol; 2018 Jul; 102(7):954-958. PubMed ID: 29051325
[TBL] [Abstract][Full Text] [Related]
22. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 study of intravitreal aflibercept.
Gonzalez VH; Boyer DS; Schmidt-Erfurth U; Heier JS; Gordon C; Benz MS; Marcus DM; Sabates NR; Vitti R; Kazmi H; Berliner AJ; Soo Y; Zhu X; Moini H; Zeitz O; Sandbrink R; Do DV
Retina; 2015 Apr; 35(4):687-94. PubMed ID: 25621943
[TBL] [Abstract][Full Text] [Related]
23. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
24. Correlation between Diabetic Retinopathy Severity and Oxygen Metabolism in Patients with Diabetic Macular Edema during Treatment with Intravitreal Aflibercept.
Blindbæk SL; Peto T; Grauslund J
Ophthalmic Res; 2020; 63(2):106-113. PubMed ID: 31715608
[TBL] [Abstract][Full Text] [Related]
25. Decrease in the number of microaneurysms in diabetic macular edema after anti-vascular endothelial growth factor therapy: implications for indocyanine green angiography-guided detection of refractory microaneurysms.
Mori K; Yoshida S; Kobayashi Y; Ishikawa K; Nakao S; Hisatomi T; Haruta M; Isihibashi T; Sonoda KH
Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):735-741. PubMed ID: 31960130
[TBL] [Abstract][Full Text] [Related]
26. Diabetic Macular Edema Treated With Intravitreal Aflibercept Injection After Treatment With Other Anti-VEGF Agents (SWAP-TWO Study)-12-Month Analysis.
Golshani C; Conti TF; Conti FF; Silva FQ; Rachitskaya A; Yuan A; Schachat A; Kaiser PK; Singh RP; Babiuch A
J Vitreoretin Dis; 2020; 4(5):364-371. PubMed ID: 37008295
[TBL] [Abstract][Full Text] [Related]
27. Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial.
Hirano T; Toriyama Y; Takamura Y; Sugimoto M; Nagaoka T; Sugiura Y; Okamoto F; Saito M; Noda K; Yoshida S; Ishibazawa A; Sawada O; Murata T
Jpn J Ophthalmol; 2021 May; 65(3):354-362. PubMed ID: 33559843
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME Studies.
Mitchell P; McAllister I; Larsen M; Staurenghi G; Korobelnik JF; Boyer DS; Do DV; Brown DM; Katz TA; Berliner A; Vitti R; Zeitz O; Metzig C; Lu C; Holz FG
Ophthalmol Retina; 2018 Oct; 2(10):988-996. PubMed ID: 31047501
[TBL] [Abstract][Full Text] [Related]
29. Ischemic index changes in diabetic retinopathy after intravitreal dexamethasone implant using ultra-widefield fluorescein angiography: a pilot study.
Querques L; Parravano M; Sacconi R; Rabiolo A; Bandello F; Querques G
Acta Diabetol; 2017 Aug; 54(8):769-773. PubMed ID: 28577137
[TBL] [Abstract][Full Text] [Related]
30. INTRAVITREAL AFLIBERCEPT INJECTION FOR CHOROIDAL NEOVASCULARIZATION DUE TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME: The HANDLE Study.
Toussaint BW; Kitchens JW; Marcus DM; Miller DM; Kingdon ML; Holcomb D; Ivey K
Retina; 2018 Apr; 38(4):755-763. PubMed ID: 28333879
[TBL] [Abstract][Full Text] [Related]
31. Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
Bressler SB; Liu D; Glassman AR; Blodi BA; Castellarin AA; Jampol LM; Kaufman PL; Melia M; Singh H; Wells JA;
JAMA Ophthalmol; 2017 Jun; 135(6):558-568. PubMed ID: 28448655
[TBL] [Abstract][Full Text] [Related]
32. Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
Clark WL; Boyer DS; Heier JS; Brown DM; Haller JA; Vitti R; Kazmi H; Berliner AJ; Erickson K; Chu KW; Soo Y; Cheng Y; Campochiaro PA
Ophthalmology; 2016 Feb; 123(2):330-336. PubMed ID: 26522708
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and Safety of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in the PLANET Study: A Randomized Clinical Trial.
Lee WK; Iida T; Ogura Y; Chen SJ; Wong TY; Mitchell P; Cheung GCM; Zhang Z; Leal S; Ishibashi T;
JAMA Ophthalmol; 2018 Jul; 136(7):786-793. PubMed ID: 29801063
[TBL] [Abstract][Full Text] [Related]
34. Repeatability of automated leakage quantification and microaneurysm identification utilising an analysis platform for ultra-widefield fluorescein angiography.
Jiang A; Srivastava S; Figueiredo N; Babiuch A; Hu M; Reese J; Ehlers JP
Br J Ophthalmol; 2020 Apr; 104(4):500-503. PubMed ID: 31320384
[TBL] [Abstract][Full Text] [Related]
35. Effect of intravitreal aflibercept on recalcitrant diabetic macular edema.
Klein KA; Cleary TS; Reichel E
Int J Retina Vitreous; 2017; 3():16. PubMed ID: 28373914
[TBL] [Abstract][Full Text] [Related]
36. Multiple Effects of Intravitreal Aflibercept on Microvascular Regression in Eyes with Diabetic Macular Edema.
Sugimoto M; Ichio A; Mochida D; Tenma Y; Miyata R; Matsubara H; Kondo M
Ophthalmol Retina; 2019 Dec; 3(12):1067-1075. PubMed ID: 31446029
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in Patients with Diabetic Macular Edema Requiring Cataract Surgery in VISTA and VIVID Studies.
Moshfeghi AA; Thompson D; Berliner AJ; Saroj N
Ophthalmol Retina; 2020 May; 4(5):481-485. PubMed ID: 31924543
[TBL] [Abstract][Full Text] [Related]
38. Classification of diabetic macular oedema using ultra-widefield angiography and implications for response to anti-VEGF therapy.
Xue K; Yang E; Chong NV
Br J Ophthalmol; 2017 May; 101(5):559-563. PubMed ID: 27531355
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.
Brown DM; Heier JS; Clark WL; Boyer DS; Vitti R; Berliner AJ; Zeitz O; Sandbrink R; Zhu X; Haller JA
Am J Ophthalmol; 2013 Mar; 155(3):429-437.e7. PubMed ID: 23218699
[TBL] [Abstract][Full Text] [Related]
40. Effect of leaking perifoveal microaneurysms on resolution of diabetic macular edema treated by combination therapy using anti-vascular endothelial growth factor and short pulse focal/grid laser photocoagulation.
Hirano T; Toriyama Y; Iesato Y; Imai A; Hirabayashi K; Nagaoka T; Takamura Y; Sugimoto M; Murata T
Jpn J Ophthalmol; 2017 Jan; 61(1):51-60. PubMed ID: 27730425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
